David E. Wheadon's Net Worth
$2.14 Million
Who is David E. Wheadon?
David E. Wheadon has an estimated net worth of $2.14 Million. This is based on reported shares across multiple companies, which include Karuna Therapeutics, Inc., Vaxart, Inc., Sotera Health Co, ChemoCentryx, Inc., Assertio Therapeutics, Inc, and Assertio Holdings, Inc..
SEC CIK
David E. Wheadon's CIK is 0001789507
Past Insider Trading and Trends
2022 was David E. Wheadon's most active year for acquiring shares with 5 total transactions. David E. Wheadon's most active month to acquire stocks was the month of May. 2024 was David E. Wheadon's most active year for disposing of shares, totalling 5 transactions. David E. Wheadon's most active month to dispose stocks was the month of February. 2020 saw David E. Wheadon paying a total of $0.00 for 310,846 shares, this is the most they've acquired in one year. In 2024 David E. Wheadon cashed out on 41,394 shares for a total of $9,240,554.20, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Karuna Therapeutics, Inc. (KRTX) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -990.00 |
$330.00 | -$326,700.00 |
0
|
Mar 18
| |||
Form 4
|
∞
| 990 |
—
|
—
| 990 |
Jun 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Vaxart, Inc. (VXRT) Snapshot price: $0.88
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +108.47% | 16K |
—
|
—
| 30.75K |
Jun 11
| |||
Form 4
| +100.00% | 7.38K |
—
|
—
| 14.75K |
Jun 26
| |||
Form 4
|
∞
| 7.38K |
—
|
—
| 7.38K |
Aug 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Sotera Health Co (SHC) Snapshot price: $15.65
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +56.29% | 20.09K |
—
|
—
| 55.78K |
May 24
| |||
Form 4
| +78.64% | 15.71K |
—
|
—
| 35.69K |
May 26
| |||
Form 4
| +114.00% | 10.64K |
—
|
—
| 19.98K |
May 27
| |||
Form 4
|
∞
| 9.34K |
—
|
—
| 9.34K |
May 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ChemoCentryx, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 26
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Assertio Therapeutics, Inc No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||